Protalix BioTherapeutics (PLX) Times Interest Earned (2016 - 2025)
Historic Times Interest Earned for Protalix BioTherapeutics (PLX) over the last 13 years, with Q1 2025 value amounting to -$690.83.
- Protalix BioTherapeutics' Times Interest Earned fell 544829.08% to -$690.83 in Q1 2025 from the same period last year, while for Sep 2025 it was $135.47, marking a year-over-year increase of 284221.35%. This contributed to the annual value of $3.69 for FY2024, which is 1213.07% up from last year.
- Protalix BioTherapeutics' Times Interest Earned amounted to -$690.83 in Q1 2025, which was down 544829.08% from $175.83 recorded in Q4 2024.
- Protalix BioTherapeutics' 5-year Times Interest Earned high stood at $175.83 for Q4 2024, and its period low was -$690.83 during Q1 2025.
- In the last 5 years, Protalix BioTherapeutics' Times Interest Earned had a median value of -$4.1 in 2023 and averaged -$32.45.
- As far as peak fluctuations go, Protalix BioTherapeutics' Times Interest Earned surged by 252371.96% in 2024, and later tumbled by 544829.08% in 2025.
- Protalix BioTherapeutics' Times Interest Earned (Quarter) stood at -$6.28 in 2021, then skyrocketed by 38.92% to -$3.84 in 2022, then plummeted by 89.0% to -$7.25 in 2023, then soared by 2523.72% to $175.83 in 2024, then crashed by 492.9% to -$690.83 in 2025.
- Its Times Interest Earned stands at -$690.83 for Q1 2025, versus $175.83 for Q4 2024 and $15.35 for Q3 2024.